This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Academisch Ziekenhuis Leiden. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Mettine H A Bos: Innovator in Prohemostatic Proteins
Introduction
Mettine H A Bos is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of biomedicine, particularly in the development of prohemostatic proteins. With a total of 4 patents, his work focuses on advancing treatments for bleeding disorders.
Latest Patents
Bos's latest patents include innovative recombinant FXa polypeptides designed to serve as antidotes. These polypeptides can completely or partially reverse the anti-coagulant effects of coagulation inhibitors, especially direct factor Xa inhibitors. His disclosures detail methods for utilizing recombinant factor Xa proteins to effectively manage bleeding in patients.
Career Highlights
Mettine H A Bos is affiliated with Academisch Ziekenhuis Leiden, where he conducts his research and development. His work has been instrumental in enhancing therapeutic options for patients suffering from bleeding complications. His expertise in this area has positioned him as a key figure in the medical research community.
Collaborations
Bos has collaborated with esteemed colleagues such as Daniël Verhoef and Pieter Hendrik Reitsma. These partnerships have fostered a collaborative environment that promotes innovation and the advancement of medical science.
Conclusion
Mettine H A Bos is a distinguished inventor whose work in prohemostatic proteins is paving the way for new treatments in the medical field. His contributions are vital for improving patient outcomes in bleeding disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile